Report explores impact of 'ultra-targeted' healthcare

As pivotal changes in healthcare and drug development gain traction, new analysis from management consultancy Arthur D Little (ADL) highlights that all sectors of the industry must evolve their business and operating models in the coming decade.

From genomic treatments to Artificial Intelligence in diagnostics to leaps in curative medicine, the healthcare ecosystem is facing unprecedented change. ADL’s forward-looking assessment is captured in a new Report, “Future Health: How the industry will move from ‘one size fits all’ to ultra-targeted care.”

Several critical shifts are pushing major players across the world to adapt: